miR-146a deficiency does not aggravate muscular dystrophy in mdx mice
Abstract Duchenne muscular dystrophy (DMD) is a genetic disease evoked by a mutation in the dystrophin gene. It is associated with progressive muscle degeneration and increased inflammation. Up to this date, mainly anti-inflammatory treatment is available for patients suffering from DMD. miR-146a is...
Main Authors: | Iwona Bronisz-Budzyńska, Katarzyna Chwalenia, Olga Mucha, Paulina Podkalicka, Karolina-Bukowska-Strakova, Alicja Józkowicz, Agnieszka Łoboda, Magdalena Kozakowska, Józef Dulak |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Skeletal Muscle |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13395-019-0207-0 |
Similar Items
-
The role of Nrf2 in acute and chronic muscle injury
by: Iwona Bronisz-Budzyńska, et al.
Published: (2020-12-01) -
Proteome Profiling of the Dystrophic <i>mdx</i> Mice Diaphragm
by: Olga Mucha, et al.
Published: (2023-11-01) -
Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout
by: Olga Mucha, et al.
Published: (2021-12-01) -
Short-term treatment with Uncaria tomentosa aggravates the injury phenotype in mdx mice
by: David Feder, et al.
Published: (2024-03-01) -
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
by: Olga Mucha, et al.
Published: (2021-09-01)